Moving the Needle on Healthcare Cost Containment & Reform

Share on Facebook
Share on Twitter
Share on
LinkedIn
+

Today, Pioneer Institute submitted recommendations to the Commonwealth of Massachusetts’ Special Senate Committee on Health Care Cost Containment and Reform. Pioneer applauds provisions of the proposed legislation that would reduce emergency room use and re-admissions, expand scope of practice, and embrace telemedicine. The Committee should also be commended for looking to other states’ accomplishments in this area.

But the current bill raises some concerns. In some instances, we believe it diminishes the potential for greater cost savings by adding unnecessary regulatory burdens. The projected savings relative to 2020 spending are quite modest, at less than 0.2 percent. The Medicaid buy-in program as it is presented is a radical change from the existing program structure – it will require more elaboration and analysis, as it is unclear what the impact of this proposal will be on MassHealth and providers across the Commonwealth. Pioneer also has concerns that the bill could lead to harmful unintended consequences, such as the collapse of the merged private insurance market. We hope the Legislature addresses these issues, but this bill starts an important healthcare cost conversation in Massachusetts, and we commend the Senate for taking the lead in this effort. Read Pioneer’s full letter to the Committee.

Get Updates On Our Healthcare Research and Events!

Related Research

New Report: Quality Adjusted Life Years (QALY) Methodology Discriminates Against Older Americans, Threatens to Deny Seniors Access to Life-Saving Care

New report asserts that with older americans more vulnerable during the COVID-19 pandemic, all health plans should avoid using the QALY methodology when assessing the value of care for older patients

COVID-19 Roundup from Pioneer: Tracking COVID-19 in MA, unemployment tsunami, cancel MCAS?, cell phone hygiene, salute to James Taylor, state tax filing & more!

/
Pioneer staff share their top picks for COVID-19 stories highlighting useful resources, best practices, and questions we should be asking our public and private sector leaders.

New Report & Legal Analysis Suggests ICER’s Quality Adjusted Life Years Methodology Violates the Americans with Disabilities Act

A new report, "The Legality of QALY under the ADA," outlines several potential legal violations and negative implications for disabled individuals related to the adoption of the QALY approach to drug value assessment, used most prominently by ICER.

Pioneer Poll: MA Healthcare Consumers Overwhelmingly Want Price Information on Services, but Few Know How to Get It

A new Pioneer poll shows seven out of ten Massachusetts workers who get their health insurance through their employers want to know the price of a healthcare procedure before they obtain it, but most of them do not how to obtain such information, even though information is already available through their insurers’ cost estimator tools.

Pioneer Institute to Present Results of New Consumer Poll Monday at State House Healthcare Price Transparency Event

BOSTON – Pioneer Institute will present the results of a new…

Report: Rare Disease Patients Hurt by “One-Size-Fits-All” ICER Framework

/
This op-ed appeared in ICERWatch on June 26, 2019. The Institute…

Putting a Price on Life: The Coming Fight Over Government Rationing of Medical Care

/
This article appeared on The Mackinac Center for Public Policy…

Public statement on new federal rule eliminating “skimming” of dues from caregivers’ Medicaid payments

Pioneer Institute applauds a new rule announced by the U.S. Centers…

Making Healthcare Prices Accessible

Today, Pioneer Institute filed a Public Comment with the federal…

Issue Brief: Problems With The Institute of Clinical and Economic Review (ICER) and the QALY Methodology

/
This article by Chris Rochester appeared in The MacIver Institute…

Commentary: Proposed Drug Price Caps Would Stall Advances in Health Care

/
This op-ed by William Smith and Adam Crepeau appeared in the…

HHS Secretary Alex Azar doesn't want drug access to become an equation

/
This op-ed by William Smith appeared in the Washington Examiner…

Action on health care pricing transparency needed to stem rising costs

/
The Hill BY JIM STERGIOS AND CHARLES CHIEPPO, OPINION CONTRIBUTORS…

ICYMI: U.S. HHS Secretary Alex Azar's Remarks on Healthcare Price Transparency, Opioid Crisis, HIV Epidemic & More

/
This past Monday, Pioneer held the 13th annual Hewitt Healthcare…